Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
The skills learned in this CME course enhanced my professional competence.
The skills learned in this CME course will be applied in the treatment of my patients
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
Assess the clinical efficacy of postoperative noninvasive positive pressure ventilation after pulmonary lobectomy.
Develop selective strategies for determining the appropriate extent of resection for individual patients to reduce organ loss.
Assess the outcomes of patients experiencing complications after robotic pulmonary resection.
Identify treatment-related factors associated with an increased risk of major complications.
Identify the benefits of robotic intervention versus thoracotomy or conventional VATS techniques.
Describe morbidity and mortality rate of complete resection associated with robotic surgery in the treatment of lung cancer.
Identify the principles of stereotactic body radiotherapy for early-stage non-small cell lung cancer.
Analyze and assess outcomes for nonoperative management of locally advanced non-small cell lung cancer.
Accurately assess and execute a thorough workup of a solitary lung nodule.
Differentiate and evaluate treatment approaches of a lung nodule versus sampled nodule and when to proceed with surgical resection.
Evaluate bronchoscopic techniques, radial endobronchial ultrasound, navigation bronchoscopy, electromagnetic navigation and robotic platforms.
Describe results of recent clinical trials that combine targeted therapies with chemotherapy.
Implement strategies that optimize therapeutic decisions for patients based on individual molecular, genomic and clinical features.
Analyze current strategies and standard of care for proper pretreatment molecular and PDL-1 testing.
Execute appropriate treatment with immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer.
Integrate gene mapping into professional practice updates when treating lung cancer.
Identify the most effective treatment plan as a result of gene mapping.
Identify new treatments for resectable lung cancer.
Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied
John Roberts, M.D. - The Value of Minimally Invasive Pulmonary Surgery
John De Rosimo, M.D. - The ABC’s of Robotic-Assisted Pulmonary Resection
Mark Dylewski, M.D. - Robotic Assisted Pulmonary Resection
Rupesh Kotecha, M.D. - Treatment of Early-Stage and Advanced Lung Cancer
Andres Sosa, M.D. - Evaluation of Pulmonary Nodules
Raul Valor, M.D. - Advanced Therapeutic Bronchoscopy for the Treatment of Lung Cancer
Paul Kaywin, M.D. - Treatment of Advanced-Stage Lung Cancer with Traditional Chemotherapy and The Role of Immunotherapy
Matthen Mathew, M.D. - “It’s all in the Genes”: However Genetics Is Changing the Face of Treatment for Lung Cancer
Frederico Albrecht, M.D. - Update on the Role of Neoadjuvant Chemotherapy